Accessibility Menu
Idt Australia logo

Idt Australia(ASX) IDT

Market CapA$19.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (1992)-38%
5 Year-89%
1 Year-36%
1 Month+47%
A$0.05
+0.00%
+0.00Today
Idt Australia last closing stock price
MetricPriceDate
Last closeAUD 0.052026-08-13
Idt Australia stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+9.3%AUD 0.042026-08-06
1 month+46.88%AUD 0.032026-07-14
3 month+17.5%AUD 0.042026-05-15
Year to date-7.84%AUD 0.052025-12-30
1 year-35.62%AUD 0.072025-08-13
3 year-29.85%AUD 0.072023-08-11
5 year-88.81%AUD 0.422021-08-13
Since inception-38.37%AUD 0.081992-01-02

Idt Australia Financials at a Glance

Market Cap

A$19.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

A$37.78M

Net Income (TTM)

-A$10.93M

EPS (TTM)

-A$0.01

P/E Ratio

-3.26

Dividend

A$0.00

Beta (Volatility)

0.22 (Low)

Price

A$0.05

Volume

89

Open

A$0.05

Previous Close

A$0.05

Daily Range

A$0.05 - A$0.05

52-Week Range

A$0.03 - A$0.07

Estimated Earnings Date

Aug 25, 2026

IDT News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Idt Australia

IDT Australia Limited is a pharmaceutical company engaged in the complete lifecycle of drug development, from research and manufacturing to global distribution. The company specializes in both active pharmaceutical ingredients (APIs) and finished dosage forms, offering a range of services including analytical support and contract manufacturing solutions.

Products and Services
  • Manufacturing of active pharmaceutical ingredients (APIs)
  • Comprehensive analytical support and quality control services
  • Medicinal cannabis products and contract manufacturing solutions
Growth Outlook
  • Recent revenue of AUD 9.72 million indicates strong market demand
  • Gross profit margin improved to 24% in the latest quarter
  • Expansion into medicinal cannabis products presents new revenue opportunities
Financial Highlights
  • Trailing twelve months (TTM) revenue of AUD 36.5 million
  • Current ratio of 2.97 suggests strong liquidity position
  • Net income for the latest quarter was AUD -1.32 million, showing potential for recovery
IDT Australia Limited operates in the healthcare sector, focusing on drug manufacturing and development. The company has established a solid foundation since its inception in 1975, with a diverse portfolio that includes both traditional pharmaceuticals and innovative medicinal cannabis products. The recent quarterly revenue of AUD 9.72 million reflects a growing demand for its services, while the gross profit margin of 24% indicates effective cost management and operational efficiency. The company's current ratio of 2.97 highlights a robust liquidity position, allowing for flexibility in meeting short-term obligations. Despite reporting a net income loss of AUD 1.32 million in the latest quarter, the overall financial health suggests potential for recovery and growth. The expansion into the medicinal cannabis market could further enhance revenue streams, positioning IDT Australia Limited as a competitive player in the pharmaceutical industry.
AI Generated • Jul 23, 2026

Industry

Pharmaceuticals

CEO

Paul McDonald

Headquarters

Boronia, VIC 3155, AU

IDT Financials

Key Financial Metrics (TTM)

Gross Margin

37.37%

Operating Margin

-29.07%

Net Income Margin

-32.26%

Return on Equity

-29.05%

Return on Capital

-19.55%

Return on Assets

-17.74%

Earnings Yield

-30.67%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

A$19.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

421.66M

Volume

89

Avg. Volume

252.20K

Financials (TTM)

Gross Profit

A$17.11M

Operating Income

-A$9.25M

EBITDA

-A$8.54M

Operating Cash Flow

-A$10.09M

Capital Expenditure

-A$2.65M

Free Cash Flow

-A$12.75M

Cash & ST Invst.

A$1.93M

Total Debt

A$9.86M

Idt Australia Performance Analysis

Idt Australia annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-06-30AUD 12,105,000N/A
20232023-06-30AUD 6,935,000-42.7%
20242024-06-30AUD 13,226,00090.7%
20252025-06-30AUD 19,217,00045.3%
Idt Australia sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-3044.7%
Q22024-12-3126.5%
Q42025-06-30-11.5%
Q22025-12-314.8%
Idt Australia annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-06-30AUD -0.00N/A
20232023-06-30AUD -0.03621.3%
20242024-06-30AUD -0.02-54.3%
20252025-06-30AUD -0.0221.9%
Idt Australia sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q42024-06-3059.6%
Q22024-12-31-72.7%
Q42025-06-30-48.7%
Q22025-12-3172.6%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

A$9.72M

+69.7%

Gross Profit

A$2.33M

+377.4%

Gross Margin

23.99%

N/A

Market Cap

A$19.82MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

A$127.04K

N/A

Employees

156

N/A

Net Income

-A$1.32M

+65.9%

EBITDA

-A$443.00K

+87.5%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

A$1.93M

-53.7%

Total Debt

A$9.86M

+328.7%

Accounts Receivable

A$6.00M

+34.3%

Inventory

A$2.50M

+80.3%

Long Term Debt

A$9.86M

+328.7%

Short Term Debt

A$0.00

N/A

Return on Assets

-17.74%

N/A

Return on Invested Capital

-18.22%

N/A

Free Cash Flow

A$676.00K

+115.3%

Operating Cash Flow

A$1.64M

+139.8%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AGH.AXAlthea Group Holdings Limited
A$0.02-4.76%
AT1.AXAtomo Diagnostics Limited
A$0.02-5.56%
RHT.AXResonance Health Limited
A$0.05+0.00%
NOX.AXNoxopharm Limited
A$0.08+6.41%

Trending Stocks

Symbol / CompanyPricePrice Chg
ONDSOndas
$8.91-0.09%
SMCISuper Micro Computer
$39.16+0.04%
SPCXSpace Exploration Technologies
$141.29-0.03%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.64+0.07%

Questions About IDT

What is the current price of Idt Australia?

Idt Australia is trading at A$0.05 per share.

What is the 52-week range for Idt Australia?

Over the past 52 weeks, Idt Australia has traded between A$0.03 and A$0.07.

How much debt does Idt Australia have?

As of the most recent reporting period, Idt Australia reported total debt of A$10.41M.

How much cash does Idt Australia have on hand?

Idt Australia reported A$503.00K in cash and cash equivalents in its most recent financial results.

What is Idt Australia’s dividend yield?

Idt Australia does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.